21242-1-AP
antibody from Proteintech Group
Targeting: TCF3
bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR
Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21242-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#21242-1-AP, RRID:AB_10755295
- Product name
- E2A antibody
- Antibody type
- Polyclonal
- Description
- E2A antibody (Cat. #21242-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references circPVT1 promotes silica-induced epithelial-mesenchymal transition by modulating the miR-497-5p/TCF3 axis.
Targeting SDCBP2 in acute myeloid leukemia.
A p38α-BLIMP1 signalling pathway is essential for plasma cell differentiation.
The role of E2A in ATPR-induced cell differentiation and cycle arrest in acute myeloid leukaemia cells.
miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
Ablation of core fucosylation attenuates the signal transduction via T cell receptor to suppress the T cell development.
Zhou S, Li Y, Sun W, Ma D, Liu Y, Cheng D, Li G, Ni C
Journal of biomedical research 2024 Mar 26;38(2):163-174
Journal of biomedical research 2024 Mar 26;38(2):163-174
Targeting SDCBP2 in acute myeloid leukemia.
Du Y, Li LL, Chen F, Du Y
Cellular signalling 2023 Dec;112:110889
Cellular signalling 2023 Dec;112:110889
A p38α-BLIMP1 signalling pathway is essential for plasma cell differentiation.
Wu J, Yang K, Cai S, Zhang X, Hu L, Lin F, Wu SQ, Xiao C, Liu WH, Han J
Nature communications 2022 Nov 28;13(1):7321
Nature communications 2022 Nov 28;13(1):7321
The role of E2A in ATPR-induced cell differentiation and cycle arrest in acute myeloid leukaemia cells.
Zhang M, Wang LF, Xu X, Du Y, Li L, Deng G, Feng Y, Ou Z, Wang K, Xu Y, Peng X, Chen F
Journal of cellular and molecular medicine 2022 Feb;26(4):1128-1143
Journal of cellular and molecular medicine 2022 Feb;26(4):1128-1143
miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
Liu T, Zou XZ, Huang N, Ge XY, Yao MZ, Liu H, Zhang Z, Hu CP
Life sciences 2019 Jun 15;227:64-73
Life sciences 2019 Jun 15;227:64-73
Ablation of core fucosylation attenuates the signal transduction via T cell receptor to suppress the T cell development.
Liang W, Mao S, Li M, Zhang N, Sun S, Fang H, Zhang J, Gu J, Wang J, Li W
Molecular immunology 2019 Aug;112:312-321
Molecular immunology 2019 Aug;112:312-321
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The E2A antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human E2A. This antibody recognizes human,mouse,rat antigen. The E2A antibody has been validated for the following applications: ELISA, WB analysis.